Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia. [electronic resource]
Producer: 19900521Description: 224-6 p. digitalISSN:- 0022-3050
- Aged
- Antiparkinson Agents -- administration & dosage
- Benserazide -- administration & dosage
- Carbidopa -- administration & dosage
- Carboxy-Lyases -- antagonists & inhibitors
- Dose-Response Relationship, Drug
- Drug Combinations -- administration & dosage
- Dyskinesia, Drug-Induced -- diagnosis
- Humans
- Hydrazines -- adverse effects
- Levodopa -- administration & dosage
- Middle Aged
- Motor Skills -- drug effects
- Neurologic Examination
- Parkinson Disease -- drug therapy
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.